FDA Inspection 730551 — Dendreon Corporation

Dendreon Corporation — FEI 3006247678

The FDA completed an inspection of Dendreon Corporation on Jan 26, 2011 in Morris Plains, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 4 citations were issued during this inspection. Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Jan 26, 2011
Fiscal Year
2011
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Morris Plains, NJ (United States)

Citations

IDCFRDescription
117721 CFR 211.63Equipment Design, Size and Location
185121 CFR 211.84(e)Rejecting When Specifications Not Met
202721 CFR 211.192Investigations of discrepancies, failures
358521 CFR 211.110(a)Control procedures to monitor and validate performance

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.